Baseline PET radiomics outperform the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma. Eertink JJ, Zwezerijnen GJ, Heymans M, Pieplenbosch S, et al. Blood 2023 Mar 31:blood.2022018558. doi: 10.1182/blood.2022018558.

Read + Share

Amedeo Smart

Independent Medical Education

Eertink JJ, Zwezerijnen GJ, Heymans M, Pieplenbosch S, et al. Baseline PET radiomics outperform the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma. Blood 2023 Mar 31:blood.2022018558. doi: 10.1182/blood.2022018558.
PMID: 37001036